Royal Oak, MI1 Active Studies

Clostridioides Difficile Infection Clinical Trials in Royal Oak, MI

Find 1 actively recruiting clostridioides difficile infection clinical trials in Royal Oak, MI. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
60
Enrolling

Recruiting Clostridioides Difficile Infection Studies in Royal Oak

About Clostridioides Difficile Infection Clinical Trials in Royal Oak

Clostridioides difficile infection is a bacterial infection that causes inflammation of the colon, often following antibiotic use. It can cause severe diarrhea and life-threatening colitis. Treatment includes specific antibiotics, and fecal microbiota transplantation for recurrent cases.

There are currently 1 clostridioides difficile infection clinical trials recruiting participants in Royal Oak, MI. These studies are seeking a combined 60 participants. Research is being sponsored by Bactolife A/S. Clinical trial participation is free and participants receive study-related medical care at no cost.

Clostridioides Difficile Infection Clinical Trials in Royal Oak — FAQ

Are there clostridioides difficile infection clinical trials in Royal Oak?

Yes, there are 1 clostridioides difficile infection clinical trials currently recruiting in Royal Oak, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Royal Oak?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Royal Oak research site will contact you about next steps.

Are clinical trials in Royal Oak free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Royal Oak studies also compensate for your time and travel.

What clostridioides difficile infection treatments are being tested?

The 1 active trials in Royal Oak are testing new therapies including novel drugs, biologics, and treatment approaches for clostridioides difficile infection.

Data updated July 14, 2026 from ClinicalTrials.gov